ArticleFrontiers in cardiovascular medicine2026

Atorvastatin and almonertinib-induced myopathy in a polypharmacy context: a case report.

Jifang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.